BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23765726)

  • 1. The lost intrinsic fragmentation of MAT1 protein during granulopoiesis promotes the growth and metastasis of leukemic myeloblasts.
    Lou S; Liu G; Shimada H; Yang X; He Q; Wu L
    Stem Cells; 2013 Sep; 31(9):1942-53. PubMed ID: 23765726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells.
    Luo P; Wang A; Payne KJ; Peng H; Wang JG; Parrish YK; Rogerio JW; Triche TJ; He Q; Wu L
    Stem Cells; 2007 Oct; 25(10):2628-37. PubMed ID: 17628022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid-regulated FGF8f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid leukemia cells.
    Chaudhry P; Yang X; Wagner M; Jong A; Wu L
    Mol Cancer Ther; 2012 Feb; 11(2):267-76. PubMed ID: 22135230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors.
    Inamoto S; Segil N; Pan ZQ; Kimura M; Roeder RG
    J Biol Chem; 1997 Nov; 272(47):29852-8. PubMed ID: 9368058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha.
    Wang JG; Barsky LW; Davicioni E; Weinberg KI; Triche TJ; Zhang XK; Wu L
    FASEB J; 2006 Oct; 20(12):2142-4. PubMed ID: 16935935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha.
    Wang J; Barsky LW; Shum CH; Jong A; Weinberg KI; Collins SJ; Triche TJ; Wu L
    J Biol Chem; 2002 Nov; 277(45):43369-76. PubMed ID: 12213824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid-modulated MAT1 ubiquitination and CAK activity.
    He Q; Peng H; Collins SJ; Triche TJ; Wu L
    FASEB J; 2004 Nov; 18(14):1734-6. PubMed ID: 15345685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH.
    Sandrock B; Egly JM
    J Biol Chem; 2001 Sep; 276(38):35328-33. PubMed ID: 11445587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities.
    Busso D; Keriel A; Sandrock B; Poterszman A; Gileadi O; Egly JM
    J Biol Chem; 2000 Jul; 275(30):22815-23. PubMed ID: 10801852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAT1-modulated CAK activity regulates cell cycle G(1) exit.
    Wu L; Chen P; Shum CH; Chen C; Barsky LW; Weinberg KI; Jong A; Triche TJ
    Mol Cell Biol; 2001 Jan; 21(1):260-70. PubMed ID: 11113200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CVB3 VP1 interacts with MAT1 to inhibit cell proliferation by interfering with Cdk-activating kinase complex activity in CVB3-induced acute pancreatitis.
    Zhang H; Zeng L; Liu Q; Jin G; Zhang J; Li Z; Xu Y; Tian H; Deng S; Shi Q; Huang X
    PLoS Pathog; 2021 Feb; 17(2):e1008992. PubMed ID: 33556114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH.
    Reardon JT; Ge H; Gibbs E; Sancar A; Hurwitz J; Pan ZQ
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6482-7. PubMed ID: 8692841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
    Rossignol M; Kolb-Cheynel I; Egly JM
    EMBO J; 1997 Apr; 16(7):1628-37. PubMed ID: 9130708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for CDK7 activation by MAT1 and Cyclin H.
    Peissert S; Schlosser A; Kendel R; Kuper J; Kisker C
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26739-26748. PubMed ID: 33055219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpd/Ercc2 regulates CAK activity and mitotic progression.
    Chen J; Larochelle S; Li X; Suter B
    Nature; 2003 Jul; 424(6945):228-32. PubMed ID: 12853965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.
    Wang A; Alimova IN; Luo P; Jong A; Triche TJ; Wu L
    FASEB J; 2010 Mar; 24(3):833-43. PubMed ID: 19917671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.
    Talukder AH; Mishra SK; Mandal M; Balasenthil S; Mehta S; Sahin AA; Barnes CJ; Kumar R
    J Biol Chem; 2003 Mar; 278(13):11676-85. PubMed ID: 12527756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corepressor MMTR/DMAP1 is involved in both histone deacetylase 1- and TFIIH-mediated transcriptional repression.
    Kang BG; Shin JH; Yi JK; Kang HC; Lee JJ; Heo HS; Chae JH; Shin I; Kim CG
    Mol Cell Biol; 2007 May; 27(10):3578-88. PubMed ID: 17371848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.